Lv2
138 积分 2024-08-19 加入
Low-dose chemotherapy remodels hepatic immune landscape and potentiates antitumor response to immune checkpoint blockade in cholangiocarcinoma
11天前
已完结
Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients
1个月前
已完结
Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial
1个月前
已完结
Multi-Institutional Development and External Validation of a Nomogram for Prediction of Extrahepatic Recurrence After Curative-Intent Resection for Hepatocellular Carcinoma
1个月前
已完结
Patients with hepatocellular carcinoma with triple-positive tumor markers may benefit from postsurgery adjuvant treatment
1个月前
已关闭
KRAS Inhibitor Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant Subclones
1个月前
已完结
An SPP1-SOCS1 pathway constrains interferon responses in tumor-associated macrophages and shapes an immunosuppressive tumor microenvironment
2个月前
已完结
CXCL12+ tumor-associated endothelial cells promote immune resistance in hepatocellular carcinoma
2个月前
已完结
PLK1-mediated phosphorylation of PHGDH reprograms serine metabolism in advanced prostate cancer
2个月前
已完结
Kupffer cell calibration of T cell responses via VSIG4–CD5 interaction promotes tumor evasion
2个月前
已完结
皖公网安备34019202002308
